Court Gives Final Approval to Dr.'s Best Glucosamine Class Action Settlement
Wolf Popper recently negotiated and obtained final Court approval of a class action settlement in a lawsuit against dietary supplement manufacturer Doctor’s Best, resulting in a payment of over $2 million to the class. The lawsuit alleged that Doctor’s Best dietary supplements labeled as containing “Glucosamine Sulfate” were mislabeled because they did not actually contain that substance, but instead contained a different substance, Glucosamine Hydrochloride, as confirmed by laboratory testing. The settlement was on behalf of a nationwide class consisting of anyone who purchased certain Doctor’s Best products labeled as containing “Glucosamine Sulfate” in the United States between July 22, 2016 and February 22, 2022. The settlement provided that settlement class members could receive $5.00 per product package if they did not have proof of purchase, subject to a five (5) product package per household maximum; or, if settlement class members did have proof of purchase, they could receive 60% of the purchase price per product package, subject to a twelve (12) product package per household maximum. Additionally, Doctor’s Best agreed for a period of three years to not represent on any labels, marketing, or advertising materials that any product offered for sale prior to the settlement contains Glucosamine Sulfate, and not to represent that any new product contains Glucosamine Sulfate unless it actually contains Glucosamine Sulfate. This is an extremely favorable result for the class, as the Court recognized. In its order granting preliminary approval of the settlement, the Court found that the settlement “provides for substantial monetary recovery,” and that “the injunctive relief provided by the Settlement Agreement addresses any future harm consumers of Doctor’s Best products would be likely to suffer as a result of the company’s labelling practices.” And in its order granting final approval, the Court noted that “the Class has reacted positively,” and that the settlement “reflects well on counsel’s skill and quality of work performed to achieve a fair settlement expeditiously.” For more information, please contact Matthew Insley-Pruitt at (212) 451-9621 or firstname.lastname@example.org.
Settlement Reached in Doctor’s Best Glucosamine Sulfate Consumer Litigation
Wolf Popper LLP serves as counsel for the plaintiff and a proposed class of consumers in litigation against Doctor’s Best, Inc., involving allegations that Doctor’s Best products labeled as containing “Glucosamine Sulfate” (the “Products”) do not actually contain Glucosamine Sulfate. Doctor’s Best denies the allegations.
The firm is pleased to announce that the parties have reached a settlement that provides Class Members with monetary relief for their purchases of these Products. Under the parties’ settlement agreement, Class Members without proof of purchase may receive a refund of five dollars ($5.00) for each Product purchased in the United States during the Class Period, subject to a five (5) packages per household maximum. Additionally, Class Members with proof of purchase may receive a refund of an amount equal to 60% of the purchase price for each Product purchased during the Class Period, subject to a twelve (12) packages per Household maximum. Doctor’s Best has also agreed to stop representing on any labels, marketing, or advertising materials that any Product it offers for sale contains Glucosamine Sulfate unless it actually contains Glucosamine Sulfate.
The Court is scheduled to hold a hearing to determine whether to preliminarily approve the settlement and send notice of its terms to Class Members. That hearing is scheduled for January 14, 2022 at 10:30 AM before Judge Josephine L. Staton of the United States District Court for the Central District of California, Ronald Reagan Federal Building and United States Courthouse, 411 W. Fourth St., Santa Ana, CA, 92701, Courtroom 10A, 10th Floor.
Additional information regarding the settlement may be found here.